Who owns LEXARIA BIOSCIENCE?

Tip: Access positions for across all investors

Analyze quarterly positions in Lexaria Bioscience with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lexaria Bioscience stock

Who bought or sold LEXARIA BIOSCIENCE this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Invenomic Capital Management 346k $194k -22% Jun 2026
 View chart
Vanguard Capital Management 298k $167k 34% Jun 2026
 View chart
Citadel Advisors 157k $88k 1061% Jun 2026
 View chart
Toronto-Dominion Bank 100k $592k -29% Jun 2026
 View chart
Vanguard Fiduciary Trust 94k $53k 0% Jun 2026
 View chart
Hrt Financial 65k $36k 252% Jun 2026
 View chart
UBS Group 47k $26k -11% Jun 2026
 View chart
Northern Trust 40k $22k 117% Jun 2026
 View chart
State Street Corporation 39k $22k 0% Jun 2026
 View chart
BlackRock 27k $15k 0% Jun 2026
 View chart
XTX Topco 22k $13k -11% Jun 2026
 View chart
Virtu Financial 19k $11k 100% Jun 2026
 View chart
Renaissance Technologies 17k $9.2k 1% Jun 2026
 View chart
Susquehanna International 15k $8.5k 100% Jun 2026
 View chart
Vanguard Global Advisers 10k $5.7k 0% Jun 2026
 View chart
Royal Bank of Canada 7.2k $4.0k 0% Jun 2026
 View chart
Crews Bank & Trust 3.9k $2.2k 100% Jun 2026
 View chart
Advisor Group Holdings 2.2k $1.2k 263% Jun 2026
 View chart
Federation des caisses Desjardins du Quebec 382.00 $213.996400 0% Jun 2026
 View chart
Tower Research Capital 152.00 $84.998400 7500% Jun 2026
 View chart

Who sold out of Lexaria Bioscience?

Fund or Company Name Date Sold Shares Held Valued At
Geode Capital Management Jun 2026 250k $140k
Intl Fcstone Jun 2026 26k $16k
Krilogy Financial Jun 2026 24k $14k
Vontobel Holding Jun 2026 15k $8.5k
Bank Of Montreal Mar 2026 14k $11k
Citigroup Mar 2026 489.00 $380.979900
FMR Jun 2026 213.00 $119.003100
Farther Finance Advisors Jun 2026 172.00 $95.993200